Cargando…
Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery
The adaptation of existing antimalarial nanocarriers to new Plasmodium stages, drugs, targeting molecules, or encapsulating structures is a strategy that can provide new nanotechnology-based, cost-efficient therapies against malaria. We have explored the modification of different liposome prototypes...
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332526/ https://www.ncbi.nlm.nih.gov/pubmed/27720930 http://dx.doi.org/10.1016/j.nano.2016.09.010 |